Table 2 |
|||||
|
Clinicopathological features of HPV-16-positive lung carcinomas |
|||||
|
All N(%) |
HPV16 positive N(%) |
HPV16 negative N(%) |
p-value |
||
|
|
|||||
|
Age |
0.669 |
||||
|
< 65 years |
38 |
4 (11) |
34 (89) |
||
|
> 65 years |
18 |
3 (17) |
15 (83) |
||
|
Gender |
0.091 |
||||
|
Male |
43 |
8 (19) |
35 (81) |
||
|
Female |
17 |
0 (0) |
17 (100) |
||
|
Histology |
< 0.001 |
||||
|
AC |
38 |
0 (0) |
38 (100) |
||
|
SQC |
18 |
8 (44) |
10 (56) |
||
|
SCLC |
4 |
0 (0) |
4 (100) |
||
|
Differentiation |
0.131 |
||||
|
Poor |
19 |
5 (26) |
14 (74) |
||
|
Moderate |
26 |
3 (12) |
23 (88) |
||
|
Well |
11 |
0 (0) |
11 (100) |
||
|
Country |
0.001 |
||||
|
Pakistan |
21 |
7 (33) |
14 (67) |
||
|
China |
31 |
0 (0) |
31 (100) |
||
|
PNG |
8 |
1 (13) |
9 (87) |
||
|
|
|||||
|
Aguayo et al. Infectious Agents and Cancer 2010 5:20 doi:10.1186/1750-9378-5-20 |
|||||
